ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug

February 20, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search